A-myb is expressed in bovine vascular smooth muscle cells during the late G1-to-S phase transition and cooperates with c-myc to mediate progression to S phase

Molecular and Cellular Biology

Volumn 17, Issue 5, 1997, Pages 2448-2457

  Marhamati, Darius J ^a   Bellas, Robert E ^a   Arsura, Marcello ^a   Kypreos, Kyriakos E ^a   Sonenshein, Gail E ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ANIMAL CELL; ARTICLE; CATTLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; MUSCLE CELL; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; TRANSACTIVATION; VASCULAR SMOOTH MUSCLE;

ANIMALIA; BOS TAURUS; BOVINAE;

EID: 0030988084     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.17.5.2448     Document Type: Article

References (71)

1. Alitalo, K., R. Winqvist, C. C. Lin, A. de la Chapelle, M. Schwab, and J. M. Bishop. 1984. Aberrant expression of an amplified c-myb oncogene in two cell lines from a colon carcinoma. Proc. Natl. Acad. Sci. USA 81:4534-4538.
2. Alterman, R.-B. M., S. Ganguly, D. H. Schulze, W. F. Marzluff, C. L. Schildkraut, and A. I. Skoultchi. 1984. Cell cycle regulation of mouse H3 histone mRNA metabolism. Mol. Cell. Biol. 4:123-132.
3. Armelin, H. B., M. C. S. Armelin, B. H. Cochran, and C. D. Stiles. 1984. Functional role for c-myc in mitogenic response to platelet-derived growth factor. Nature (London) 310:655-660.
4. Badiani, P., P. Corbella, D. Kiussis, J. Marvel, and K. Weston. 1994. Dominant interfering alleles define a role for c-Myb in T-cell development. Genes Dev. 8:770-782.
5. Beldekas, J. C., L. Gerstenfeld, G. E. Sonenshein, and C. Franzblau. 1982. Cell density and estradiol modulation of procollagen type III in cultured calf smooth muscle cells. J. Biol. Chem. 257:12252-12256.
6. Biedenkapp, H., U. Borgmeyer, A. E. Sippel, and K.-H. Klempnauer. 1988. Viral myb oncogene encodes a sequence-specific DNA binding activity. Nature (London) 335:835-837.
7. Brown, K. E., M. S. Kindy, and G. E. Sonenshein. 1992. Expression of the c-myb proto-oncogene in bovine vascular smooth muscle cells. J. Biol. Chem. 267:4625-4630.
8. Brown, K. E., R. Lawrence, and G. E. Sonenshein. 1991. Concerted modulation of α1(XI) and α2(V) collagen mRNA in bovine vascular smooth muscle cells. J. Biol. Chem. 266:23268-23273.
9. Burk, O., S. Mink, M. Ringwald, and K.-H. Klempnauer. 1993. Synergistic activation of the chicken mim-1 gene by v-myb and C/EBP transcription factors. EMBO J. 12:2027-2038.
10. Chamley-Campbell, J., G. R. Campbell, and R. Ross. 1979. The smooth muscle cell in culture. Physiol. Rev. 59:1-61.
11. Chen, C., and H. Okayama. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745-2752.
12. Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299.
13. Clarke, M. F., J. F. Kukowska-Latallo, E. Westin, M. Smith, and E. Prochownik. 1988. Constitutive expression of a c-myb cDNA blocks Friend murine erythroleukemia cell differentiation. Mol. Cell. Biol. 8:884-892.
14. Cogswell, J., P. C. Cogswell, W. M. Kuehl, A. M. Cuddihy, T. M. Bender, U. Engelke, K. B. Marcu, and J. P.-Y. Ting. 1993. Mechanism of c-myc regulation by c-Myb in different cell lineages. Mol. Cell. Biol. 13:2858-2869.
15. Dudek, H., R. V. Tantravahi, V. N. Rao, E. S. P. Reddy, and E. P. Reddy. 1992. Myb and Ets proteins cooperate in transcriptional activation of the mim-1 promoter. Proc. Natl. Acad. Sci. USA 89:1291-1295.
16. Duyao, M., D. J. Kessler, D. B. Spicer, C. Bartholomew, J. L. Cleveland, M. Siekevitz, and G. E. Sonenshein. 1992. Transactivation of the c-myc promoter by the HTLV-1 tax gene. J. Biol. Chem. 267:16288-16291.
17. Dyson, P. J., F. Poirier, and R. J. Watson. 1989. Expression of c-myb in embryonal carcinoma cells and embryonal stem cells. Differentiation 42:24-27.
18. Evans, J. L., T. Moore, W. M. Kuehl, T. Bender, and P.-Y. Ting. 1990. Functional analysis of c-Myb protein in T-lymphocytic cell lines shows that it trans-activates the c-myc promoter. Mol. Cell. Biol. 10:5747-5752.
19. Feinberg, A., and B. Vogelstein. 1982. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:6-9.
20. Foos, G., S. Grimm, and K.-H. Klempnauer. 1992. Functional antagonism between members of the myb family: B-myb inhibits v-myb induced gene activation. EMBO J. 11:4619-4629.
21. Foos, G., S. Grimm, and K.-H. Klempnauer. 1994. The chicken A-myb protein is a transcriptional activator. Oncogene 9:2481-2488.
22. Foos, G., S. Natour, and K.-H. Klempnauer. 1993. TATA-box dependent trans-activation of the human HSP70 promoter by Myb proteins. Oncogene 3:1775-1782.
23. 1/S transition in normal human T-lymphocytes requires the nuclear protein encoded by c-myb. Science 245:180-183.
24. Gewirtz, A. M., and B. Calabretta. 1988. A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro. Science 242:1303-1306.
25. Golay, J., A. Capucci, M. Arsura, M. Castellano, V. Rizzo, and M. Introna. 1991. Expression of c-myfr and B-myb, but not A-myb, correlates with proliferation in human hematopoietic cells. Blood 77:149-158.
26. Golay, J., E. Erba, S. Bernasconi, G. Peri, and M. Introna. 1994. The A-myb gene is highly expressed in tonsillar germinal center CD38+, CD39-, sIgM-B lymphocytes and in Burkitt's lymphoma cell lines. J. Immunol. 153:543-553.
27. Golay, J., L. Loffarelli, M. Luppi, M. Castellano, and M. Introna. 1994. The human A-myb protein is a strong activator of transcription. Oncogene 9:2469-2479.
28. Gonda, T. J., and D. Metcalf. 1984. Expression of myb, myc and fos proto-oncogenes during the differentiation of a murine myeloid leukaemia. Nature (London) 310:249-251.
29. Greenberg, M. E., and E. B. Ziff. 1984. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature (London) 311:433-438.
30. Howe, K. M., and R. J. Watson. 1991. Nucleotide preferences in sequence-specific recognition of DNA by c-myb protein. Nucleic Acids Res. 1:3913-3919.
31. Ibanez, C. E., and J. S. Lipsick. 1990. Transactivation of gene expression by v-myb. Mol. Cell. Biol. 10:2285-2293.
32. Introna, M., J. Golay, J. Frampton, T. Nakano, S. Ness, and T. Graf. 1990. Mutations in v-myb alter the differentiation of myelomonocytic cells transformed by the oncogene. Cell 63:1287-1297.
33. Kaczmarek, L., J. K. Hyland, R. Watt, M. Rosenberg, and R. Baserga. 1985. Microinjected c-myc as a competence factor. Science 228:1313-1315.
34. Kelly, K., B. Cochran, C. Stiles, and P. Leder. 1983. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 35:603-610.
35. Kenney, S. C., E. Holley-Guthrie, E. B. Quinlivan, D. Gutsch, Q. Zhang, T. Bender, J.-F. Giot, and A. Sergeant. 1992. The cellular oncogene c-myb can interact synergistically with the Epstein-Barr virus BZLF1 transactivator in lymphoid cells. Mol. Cell. Biol. 12:136-146.
36. Kindy, M. S., and G. E. Sonenshein. 1986. Regulation of oncogene expression in cultured aortic smooth muscle cells. J. Biol. Chem. 261:12865-12868.
37. Klagsbrun, M., and E. Edelman. 1989. Biological and biochemical properties of fibroblast growth factors: implications for the pathogenesis of atherosclerosis. Atherosclerosis 9:269-278.
38. Ku, D.-H., S.-C. Wen, A. Engelhard, N. C. Nicolaides, K. E. Lipson, T. A. Marino, and B. Calabretta. 1993. c-myb transactivates cdc2 expression via Myb binding sites in the 5′-flanking region of the human cdc2 gene. J. Biol. Chem. 268:2255-2259.
39. Lam, E. W.-F., and R. J. Watson. 1993. An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription. EMBO J. 12:2705-2713.
40. Lawrence, R., L.-J. Chang, U. Siebenlist, P. Bressler, and G. E. Sonenshein. 1994. Vascular smooth muscle cells express a constitutive NF-κB-like activity. J. Biol. Chem. 269:28913-28918.
41. Lindner, V., and M. A. Reidy. 1991. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc. Natl. Acad. Sci. USA 88:3739-3743.
42. Lipsick, J. S., and W. J. Boyle. 1987. c-myb protein expression is a late event during T-lymphocyte activation. Mol. Cell. Biol. 7:3358-3360.
43. Marhamati, D., R. Moreland, and G. Sonenshein. Unpublished observations.
44. Marhamati, D. J., and G. E. Sonenshein. 1996. B-Myb expression in vascular smooth muscle cells occurs in a cell cycle dependent fashion and down-regulates promoter activity of type 1 collagen. J. Biol. Chem. 271:3359-3365.
45. McClinton, D., J. Staggord, L. Brents, T. Bender, and W. M. Kuehl. 1990. Differentiation of mouse erythroleukemia cells is blocked by late up-regulation of a c-myb transgene. Mol. Cell. Biol. 10:705-710.
46. McConlogue, L., M. Gupta, L. Wu, and P. Coffino. 1984. Molecular cloning and expression of the mouse ornithine decarboxylase gene. Proc. Natl. Acad. Sci. USA 81:540-544.
47. Mettus, R. V., J. Litvin, A. Wall, A. Toscani, K. Latham, K. Hatton, and E. P. Reddy. 1994. Murine A-myb: evidence for differential splicing and tissue-specific expression. Oncogene 9:3077-3086.
48. Moscovici, C. 1975. Leukemia transformation with avian myeloblastosis virus: present status. Curr. Top. Microbiol. Immunol. 71:79-101.
49. Mucenski, M. L., K. McLain, A. B. Kier, S. H. Swerdlow, C. M. Schreiner, T. A. Miller, D. W. Pietryga, W. J. Scott, Jr., and S. S. Potter. 1991. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 65:677-689.
50. Nakagoshi, H., C. Kanei-Ishii, T. Sawazaki, G. Mizuguchi, and S. Ishii. 1992. Transcriptional activation of the c-myc gene by the c-myb and B-myb gene products. Oncogene 7:1233-1240.
51. Ness, S. A., A. Marknell, and T. Graf. 1989. The v-myb oncogene product binds to and activates the promyelocytic-specific mim-1 gene. Cell 59:1115-1125.
52. Newby, A. C., and S. J. George. 1993. Proposed roles for growth factors in mediating smooth muscle proliferation in vascular pathologies. Cardiovasc. Res. 27:1173-1183.
53. Nicolaides, N. C., R. Gualdi, C. Casadevall, L. Manzella, and B. Calabretta. 1991. Positive autoregulation of c-myb expression via Myb binding sites in the 5′ flanking region of the human c-myb gene. Mol. Cell. Biol. 11:6166-6176.
54. Nomura, N., M. Takahashi, M. Matsui, S. Ishii, T. Date, S. Sasamoto, and R. Ishizake. 1988. Isolation of human cDNA clones of myb-related genes, A-myb and B-myb. Nucleic Acids Res. 16:11075-11083.
55. Pardee, A. B. 1989. G1 events and regulation of cell proliferation. Science 246:603-608.
56. Poole, J. C. F., S. B. Cromwell, and E. P. Benditt. 1971. Behavior of smooth muscle cells and formation of extracellular structures in the reaction of arterial walls to injury. Am. J. Pathol. 62:391-404.
57. Reilly, C. F., M. S. Kindy, K. E. Brown, R. D. Rosenberg, and G. E. Sonenshein. 1989. Heparin prevents vascular smooth muscle cell progression through the G1 phase of the cell cycle. J. Biol. Chem. 264:6990-6995.
58. Reiss, K., A. Ferber, S. Travail, P. Porcu, P. D. Phillips, and R. Baserga. 1991. The protooncogene c-myb increases the expression of insulin-like growth factor 1 and insulin-like growth factor 1 receptor messenger RNAs by a transcriptional mechanism. Cancer Res. 51:5997-6000.
59. Ross, R. 1993. Pathogenesis of atherosclerosis: a perspective for the 1990's. Science 362:801-809.
60. Sakura, H., C. Kanei-Ishii, T. Nagase, H. Nakagoshi, T. J. Gonda, and S. Ishii. 1989. Delineation of three functional domains of the transcriptional activator encoded by the c-myb proto-oncogene. Proc. Natl. Acad. Sci. USA 86:5758-5762.
61. Schwartz, S. M., M. R. Reidy, and A. Clowes. 1985. Kinetics of atherosclerosis: a stem cell model. J. Atheroscler. Res. 454:292-304.
62. Simons, M., and R. D. Rosenberg. 1992. Antisense nonmuscle myosin heavy chain and c-myb oligonucleotides suppress smooth muscle cell proliferation in vitro. Circ. Res. 70:835-843.
63. Sleeman, J. P. 1993. Xenopus A-myb is expressed during early spermatogenesis. Oncogene 8:1931-1941.
64. 1 progression and c-myb expression. Science 233:203-206.
65. Strauss, B. H., R. J. Chisholm, F. W. Keeley, A. I. Gotlieb, R. A. Logan, and P. W. Armstrong. 1994. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ. Res. 75:650-658.
66. Takahashi, T., H. Nakagoshi, A. Sarai, N. Nomura, T. Yamamoto, and S. Ishii. 1995. Human A-myb gene encodes a transcriptional activator containing the negative regulatory domains. FEBS Lett. 358:89-96.
67. Thiele, C. J., P. S. Cohen, and M. A. Israel. 1988. Regulation of c-myb expression in human neuroblastoma cells during retinoic acid-induced differentiation. Mol. Cell. Biol. 8:1677-1683.
68. Trauth, K., B. Mutschler, N. A. Jenkins, D. J. Gilbert, N. G. Copeland, and K.-H. Klempnauer. 1994. Mouse A-myb encodes a trans-activator and is expressed in mitotically active cells of the developing central nervous system, adult testis and B lymphocytes. EMBO J. 13:5994-6005.
69. Watson, R. J., C. Robinson, and E. W. Lam. 1993. Transcription regulation by murine B-myb is distinct from that by c-myb. Nucleic Acids Res. 21:267-272.
70. Weston, K., and J. M. Bishop. 1989. Transcriptional activation by the v-myb oncogene and its cellular progenitor, c-myb. Cell 58:85-93.
71. Zobel, A., F. Kalkbrenner, S. Guebmann, M. Nawrath, G. Vorbrueggen, and K. Moelling. 1991. Interaction of the v- and c-myb proteins with regulatory sequences of the human c-myc gene. Oncogene 6:1397-1407.